This phenomenon is not surprising, provided that subsets of AD patients exhibit certain T2DM features, such as high fasting insulin levels, insulin resistance (i.e., the resistance of tissues in charge of glucose disposal to the actions of insulin), and glucose intolerance [9]. Here, INS is linked to Alzheimer disease.